Century Therapeutics, Inc.
USD2.41
+0.09 (+3.88%)
CEO
Brent Pfeiffenberger
IPO Date
2021-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.35
Prev. Close
$2.32
Day Low
$2.17
Day High
$2.50
52W Low
$0.43
52W High
$3.04
Market Cap
$0.21B
Volume
1.85M
| -0.6 |
| 31 Dec 2023 | FY | 100.0% | -6115.1% | -74.0% | -37.9% | 0.26 | 9.92 | -1.4 |
| 31 Dec 2022 | FY | 100.0% | -2518.4% | -43.2% | -26.9% | 0.16 | 10.72 | -2.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -24.2% | -21.9% | 0.06 | 14.57 | -9.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 50.3% | -50.2% | -0.20 | 6.51 | -23.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 266.5% | -269.3% | 0.00 | 28.10 | -5.1 |
| -1.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -19.5% | -14.1% | 0.25 | 6.25 | -0.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -15.5% | -11.4% | 0.25 | 10.72 | -0.4 |
| 31 Mar 2025 | Q1 | 100.0% | 70.1% | 31.8% | 24.3% | 0.22 | 11.70 | 0.1 |
| 31 Dec 2024 | Q4 | 100.0% | -864.4% | -22.4% | -10.2% | 0.33 | 1.50 | -0.6 |
| 30 Sept 2024 | Q3 | 100.0% | -3947.7% | -16.0% | -8.0% | 0.28 | 10.39 | -1.2 |
| 30 Jun 2024 | Q2 | 100.0% | -4047.6% | -14.1% | -7.5% | 0.25 | 10.62 | -1.6 |
| 31 Mar 2024 | Q1 | 100.0% | -3282.1% | -15.8% | -8.1% | 0.26 | 12.44 | -2.2 |
| 31 Dec 2023 | Q4 | -8219.4% | -14700.7% | -21.3% | -10.9% | 0.26 | 9.92 | -1.3 |